BYOMass Company
BYOMass is developing therapeutics to modulate the central control of metabolism associated with aging and age-related chronic illnesses.
Total Funding:
1500000
Investor Type:
Company
Technology:
Geroscience
Last Funding Type:
Venture - Series Unknown
Founded Date:
2017
Industry:
Biotechnology
Employee Number:
1-10
Last Funding Date:
2019
Number Of Exists:
Venture - Series Unknown
Headquarters:
Sudbury, Massachusetts, United States
Investors Number:
1